B. Braun Melsungen AG, a German-based medical device company, and its United States subsidiary B. Braun Medical have obtained a permanent injunction in its patent infringement case against Japanese company Terumo, according to a B. Braun news release.
The District Court for the District of Delaware granted an immediate and permanent order to cease Terumo and Terumo Medical's production of the Surshield Safety IV Catheter in the acute care market. The order also precludes Terumo from bidding against B. Braun on expiring group purchasing organization contracts.
Terumo is permitted to sell the catheter into the alternative care market until June 1, 2012. After that date, the company will no longer be able to make, sell, use or offer the catheter in the United States.
B. Braun will seek damages and other relief for the infringement.
Read the release on the B. Braun patent infringement.
Read Articles Related to B. Braun:
B. Braun Reports 9.8% Sales Growth for FY 2010
German Medical Device Market Estimated at $17.5B
Aesculap Implant System, a B. Braun Company, Launches New Patient Education Website
The District Court for the District of Delaware granted an immediate and permanent order to cease Terumo and Terumo Medical's production of the Surshield Safety IV Catheter in the acute care market. The order also precludes Terumo from bidding against B. Braun on expiring group purchasing organization contracts.
Terumo is permitted to sell the catheter into the alternative care market until June 1, 2012. After that date, the company will no longer be able to make, sell, use or offer the catheter in the United States.
B. Braun will seek damages and other relief for the infringement.
Read the release on the B. Braun patent infringement.
Read Articles Related to B. Braun:
B. Braun Reports 9.8% Sales Growth for FY 2010
German Medical Device Market Estimated at $17.5B
Aesculap Implant System, a B. Braun Company, Launches New Patient Education Website